Compare ACU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACU | CDXS |
|---|---|---|
| Founded | 1867 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.0M | 141.8M |
| IPO Year | N/A | 2010 |
| Metric | ACU | CDXS |
|---|---|---|
| Price | $41.44 | $1.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.1K | ★ 1.1M |
| Earning Date | 02-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $194,960,991.00 | $52,932,000.00 |
| Revenue This Year | $2.19 | $15.64 |
| Revenue Next Year | $4.55 | $5.23 |
| P/E Ratio | $17.26 | ★ N/A |
| Revenue Growth | ★ 2.35 | N/A |
| 52 Week Low | $34.35 | $1.52 |
| 52 Week High | $45.25 | $5.43 |
| Indicator | ACU | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 64.21 | 45.13 |
| Support Level | $38.83 | $1.58 |
| Resistance Level | $43.13 | $1.74 |
| Average True Range (ATR) | 1.10 | 0.07 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 74.89 | 41.18 |
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.